ResMed, Inc. (RMD)

259.51 +4.84 (+1.90%) USD  |  NYSE  |  Jan 14, 16:00
259.56 +0.06 (+0.02%) Pre-Market: 20:00
More

ResMed CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for RMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Abbott Laboratories Upgrade
Stryker Corp. Upgrade
West Pharmaceutical Services, Inc. Upgrade
Insulet Corp. Upgrade